Identification of predictors of response to Erenumab in a cohort of patients with migraine - Houssein Salem-Abdou, David Simonyan, Jack Puymirat, 2021
Source : https://journals.sagepub.com/doi/full/10.1177/25158163211026646
Abstract Background: The migraine-specific monoclonal antibody Erenumab targeting the calcitonin gene related peptide receptor is an effective and well tolerated preventive treatment of episodic and chronic migraine. However, its price...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrThis is really interesting, it may help to tease out different subcategories of patients.
Evidence supports prophylactic treatment for migraine
Explore millions of resources from scholarly journals, books, newspapers, videos and more, on the ProQuest Platform.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrThis is well known and preventive treatment is very underused.
Thalamo-cortical networks in subtypes of migraine with aura patients
Source : https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-021-01272-0
Background We searched for differences in resting-state functional connectivity (FC) between brain networks and its relationship with the microstructure of the thalamus between migraine with pure visual auras (MA), and...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrGood basic science review.
Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura, Hemiplegic Migraine, and Retinal Migraine
Clinical Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura, Hemiplegic Migraine, and Retinal Migraine - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/32476572/?from_single_result=Clinical
All migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients experienced migraine with or without typical aura, and some patients having other coexisting headaches also had high PedMIDAS and...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrInteresting review.
Characterizing opioid use in a US population with migraine
Source : https://n.neurology.org/content/early/2020/06/10/WNL.0000000000009324.abstract
Objective To determine the prevalence of and risk factors associated with opioid use in the treatment of migraine, we examined demographics and clinical characteristics of 867 individuals who reported using...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrAlthough neurologists are moving away from using opiods, it is still a widely used medication but with many side effects.